"The Dallas Lasik surgeons of Cornea Associates of Texas offer eye care treatments including: Lasik surgery, cornea transplant, cataract surgery and more! Comprised of some of the Dallas region's leading cornea specialists and LASIK surgeons, Cornea Associates of Texas is dedicated to achieving exceptional laser eye surgery results, providing first-rate customer service, staying abreast of the latest technological and surgical developments, and offering outstanding pre- and post- laser eye surgery care to patients at our Plano, Dallas, and Fort Worth, Texas locations. For a free laser eye surgery consultation, contact our practice today."

During the past decade, Cornea Associates of Texas conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cornea Associates of Texas" #1 sponsor was "Cornea Associates of Texas" with 2 trials, followed by "Cxlusa" with 2 trials sponsored, "Lux Biosciences, Inc." with 2 trials sponsored, "Case Western Reserve University" with 1 trials sponsored and "Johnson & Johnson Surgical Vision, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cornea Associates of Texas" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cornea Associates of Texas" are "Keratoconus" (4 trials), "Corneal Degeneration" (2 trials), "Corneal Diseases" (2 trials), "Corneal Ectasia" (2 trials) and "Pellucid Marginal Corneal Degeneration" (2 trials). Many other conditions were trialed in "Cornea Associates of Texas" in a lesser frequency.

Most popular intervention types in "Cornea Associates of Texas" are "Combination Product" (3 trials), "Drug" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "LX201" (2 trials), "PXL-330 Platinum device for crosslinking with Peschke riboflavin solution" (2 trials), "Placebo" (2 trials), "CXLO Corneal Strengthening Solution and UVA Illumination Device" (1 trials) and "Cornea tissue transplant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cornea Associates of Texas" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Cornea Associates of Texas". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cornea Associates of Texas, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cornea Associates of Texas, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".